MBX-102

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MBX-102, covering 2014-07-28 to 2015-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout [Phase 2]